Johnson & Johnson in talks to buy Dutch biotech firm Crucell for $2.29 billion
Johnson & Johnson plans to buy Crucell for $2.3B) Suriname’s new president back in power after weeklong illness; confirms had denguemore images Anxiety ridden heart patients face higher death riskAP answers your questions on the news, from sex addiction treatments to the Toyota recall
Ask AP: Sex addiction, the Toyota recall Now that sex addiction has found its poster child in Tiger Woods, more people are familiar with the affliction. Yet how it’s treated remains a mystery to many. Dutch group pushing for right to suicide for people older than 70 gains support
Dutch group endorses right to suicide for elderly Dutch fashion designer Edgar Vos, who dressed stars and royals, dies at age 78Studies: Switching antiseptic prep, screening patients for bacteria cut post-op infectionsmore images Johnson & Johnson takes 18 percent stake in Crucell for euro301.8 millionJohnson & Johnson buys 18 percent stake in Crucell AMSTERDAM — U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in biotechnology company Crucell NV for €301.8 million ($440 million), the Dutch company said in a statement Monday. Research shows statin use reduces heart attacks, deaths after surgery on blood vesselsStatin cuts heart problems after artery surgery NEW YORK — Score another victory for the cheap, cholesterol-lowering wonder drugs known as statins. People getting an artery unclogged or repaired were much less likely to die or have a heart attack afterward if they took preventive doses of the pills before and after their operations, a Dutch study showed. |
|